Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Expert Opinion on Therapeutic Patents|November 6, 2015
Indole-2-carboxamide derivatives: a patent evaluation of WO2015036412A1Jan Zitko, Martin DolezalExpert Opinion on Therapeutic Patents|December 20, 2014
Pyrazine derivatives: a patent review (June 2012 - present)Martin Dolezal, Jan ZitkoCurrent Pharmaceutical Design|November 15, 2011
Antimycobacterial evaluation of pyrazinoic acid reversible derivativesMartin Dolezal, Diana Kesetovic, Jan ZitkoJournal of Enzyme Inhibition and Medicinal Chemistry|November 11, 2014
Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decadeOndrej Holas, Pavel Ondrejcek, Martin DolezalMolecules (Basel, Switzerland)|November 3, 2011
Pyrazinecarboxamides as potential elicitors of flavonolignan and flavonoid production in Silybum marianum and Ononis arvensis cultures in vitroLenka Tumova, Jiri Tuma, Martin DolezalMedicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivativesJosef Jampilek, Martin Dolezal, Vladimir BuchtaThe International Journal of Press/Politics|December 2, 2016
Negative Campaigning and the Logic of Retaliation in Multiparty CompetitionMartin Dolezal, Laurenz Ennser-Jedenastik, Wolfgang C MüllerParty Politics|October 10, 2017
Who will attack the competitors? How political parties resolve strategic and collective action dilemmas in negative campaigningMartin Dolezal, Laurenz Ennser-Jedenastik, Wolfgang C MüllerMolecules (Basel, Switzerland)|January 30, 2010
Substituted pyrazinecarboxamides as abiotic elicitors of flavolignan production in Silybum marianum (L.) gaertn cultures in vitroLenka Tůmová, Jirí Tůma, Klara Megusar, et al.Current Medicinal Chemistry|February 14, 2006
5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agentsJosef Jampilek, Martin Dolezal, Veronika Opletalova, et al.Pageof 5